Compared to other tumors, glioblastoma (GBM) is extremely difficult to treat. Recently, photothermal therapy (PTT) has demonstrated advanced therapeutic efficacy; however, because of the relatively low tissueâpenetration efficiency of laser light, its application in deepâseated tumors remains challenging. Herein, bradykinin (BK) aggregationâinducedâemission nanoparticles (BK@AIE NPs) are synthesized; these offer selective penetration through the bloodâtumor barrier (BTB) and strong absorbance in the nearâinfrared region (NIR). The BK ligand can prompt BTB adenosine receptor activation, which enhances transportation and accumulation inside tumors, as confirmed by T1âweighted magnetic resonance and fluorescence imaging. The BK@AIE NPs exhibit high photothermal conversion efficiency under 980Â nm NIR laser irradiation, facilitating the treatment of deepâseated tumors. Tumor progression can be effectively inhibited to extend the survival span of mice after spatiotemporal PTT. NIR irradiation can eradicate tumor tissues and release tumorâassociated antigens. It is observed that the PTT treatment of GBMâbearing mice activates natural killer cells, CD3+ T cells, CD8+ T cells, and M1 macrophages in the GBM area, increasing the therapeutic efficacy. This study demonstrates that NIRâassisted BK@AIE NPs represent a promising strategy for the improved systematic elimination of GBMs and the activation of local brain immune privilege.